ClinicalTrials.Veeva

Menu

Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder)

Stony Brook University logo

Stony Brook University

Status and phase

Withdrawn
Phase 2

Conditions

Frozen Shoulder
Adhesive Capsulitis

Treatments

Drug: Collagenase

Study type

Interventional

Funder types

Other

Identifiers

NCT00261196
Shoulder 202

Details and patient eligibility

About

The purpose of this study is to test collagenase injection therapy to dissolve adhesions causing frozen shoulder.

Full description

In a random, placebo controlled, double blind study, collagenase injection therapy will be investigated for it's ability to lyse the adhesions associated with the shoulder capsule in adhesive capsulitis (frozen shoulder).

Treatment success may obviate the need for extensive physical therapy and/or shoulder arthroscopy (surgery) to correct this condition and restore normal and pain free shoulder motion.

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of frozen shoulder of at least one month duration

Exclusion criteria

  • shoulder arthritis
  • rotator cuff tears
  • any chronic, serious, uncontrolled medical condition
  • inability to conform to study visits (20-30 per year)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Triple Blind

0 participants in 2 patient groups, including a placebo group

Collagenase
Experimental group
Description:
Collagenase Injection
Treatment:
Drug: Collagenase
Placebo
Placebo Comparator group
Description:
Placebo Injection
Treatment:
Drug: Collagenase

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems